• Lysine has been claimed to be effective in the treatment and prevention of episodes of recurrent herpes simplex (HS) infection. We carried out a double-blind, placebo-controlled trial of oral lysine hydrochloride therapy (400 mg, three times a day) in a group of 21 patients in good general health with a history of frequently recurring infection. Using our measures of episode frequency, duration, and severity, we were unable to detect any substantial benefit of lysine therapy either as a treatment for episodes in progress or as a prophylactic drug for the prevention of recurrences. We conclude that it is unlikely that lysine improves frequently recurrent HS infections in the majority of patients.
(Arch Dermatol 1984;120:48-51)
DiGiovanna JJ, Blank H. Failure of Lysine in Frequently Recurrent Herpes Simplex Infection: Treatment and Prophylaxis. Arch Dermatol. 1984;120(1):48–51. doi:10.1001/archderm.1984.01650370054010
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: